Artificial intelligence and hemodynamic studies in optical coherence tomography angiography for diabetic retinopathy evaluation: A review.
K PradeepVijay JeyakumarMuna BhendeAreeba ShakeelShriraam MahadevanPublished in: Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine (2023)
Diabetic retinopathy (DR) is a rapidly emerging retinal abnormality worldwide, which can cause significant vision loss by disrupting the vascular structure in the retina. Recently, optical coherence tomography angiography (OCTA) has emerged as an effective imaging tool for diagnosing and monitoring DR. OCTA produces high-quality 3-dimensional images and provides deeper visualization of retinal vessel capillaries and plexuses. The clinical relevance of OCTA in detecting, classifying, and planning therapeutic procedures for DR patients has been highlighted in various studies. Quantitative indicators obtained from OCTA, such as blood vessel segmentation of the retina, foveal avascular zone (FAZ) extraction, retinal blood vessel density, blood velocity, flow rate, capillary vessel pressure, and retinal oxygen extraction, have been identified as crucial hemodynamic features for screening DR using computer-aided systems in artificial intelligence (AI). AI has the potential to assist physicians and ophthalmologists in developing new treatment options. In this review, we explore how OCTA has impacted the future of DR screening and early diagnosis. It also focuses on how analysis methods have evolved over time in clinical trials. The future of OCTA imaging and its continued use in AI-assisted analysis is promising and will undoubtedly enhance the clinical management of DR.
Keyphrases
- diabetic retinopathy
- artificial intelligence
- optical coherence tomography
- deep learning
- editorial comment
- machine learning
- big data
- high resolution
- clinical trial
- convolutional neural network
- end stage renal disease
- primary care
- optic nerve
- newly diagnosed
- ejection fraction
- chronic kidney disease
- risk assessment
- case control
- human health
- mass spectrometry
- patient reported outcomes